IMB-Based Sleep Hygiene Education for Menopausal Women: Effects on Sleep Quality and Depression

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age45-60
SponsorAnkara Yildirim Beyazıt University

About this trial

This study aims to evaluate the effects of sleep hygiene education on sleep quality and depression in women during menopause. Women will be randomly assigned to either an education group or a control group. The education group will receive training based on the Information-Motivation-Behavioral Skills (IMB) Model. Sleep quality and depression levels will be measured before and after the education. The results will provide insight into whether sleep hygiene education can improve sleep quality and reduce depression in menopausal women.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Being in menopause

Being between 40 and 60 years of age

Having a low sleep quality score according to the Menopause-Specific Sleep Quality Scale.

Being willing to participate in the study.

Disqualifiers

Having a history of receiving psychological support.

Having been diagnosed with a chronic psychiatric illness (previously diagnosed depression, anxiety disorder, etc.).

Having a neurological or chronic systemic illness that may affect sleep quality.

Being treated for a sleep disorder (receiving medication or psychotherapy).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Sleep Hygiene Education

    Behavioral

    Education based on the IMB Model targeting sleep habits, routines, and sleep hygiene behaviors to improve sleep quality.

Treatment groups

500 Participants
are divided into 2 treatment groups
Group A: Sleep Hygiene EducationExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Sleep Quality

Change in sleep quality measured using the Menopause-Specific Sleep Quality Scale before and after the sleep hygiene education intervention.

Time frame
Baseline and 10 weeks after intervention

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.